Glazer Capital portfolio
Type not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 17, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Glazer Capital reported a $3.9 bn portfolio of 334 companies (531 positions, counting each share class separately) to the SEC as of the end of Q2 2026. Its largest positions are JHG, Nuvalent, Apogee Therapeutics. During the quarter it opened Nuvalent and Apogee Therapeutics.
Sections with a free account
What it reported after the quarter end (Q2 2026)
The 13F shows the portfolio as of Jun 30, 2026. Since then Glazer Capital has filed these own trades with the SEC (Form 4, when it owns more than 10% of a company or holds a role in it) and stakes above 5% (13D and 13G). It is not everything it did: only what it must report before the next 13F.
Stake reported in the company · event of Oct 13, 2026 · filed Oct 20, 2026 · filing ↗
Stake reported in the company · event of Oct 9, 2026 · filed Oct 16, 2026 · filing ↗
Stake reported in the company · event of Oct 2, 2026 · filed Oct 9, 2026 · filing ↗
Stake reported in the company · event of Oct 2, 2026 · filed Oct 9, 2026 · filing ↗
Stake reported in the company · event of Sep 29, 2026 · filed Oct 6, 2026 · filing ↗
Stake reported in the company · event of Sep 25, 2026 · filed Oct 2, 2026 · filing ↗
Stake reported in the company · event of Sep 23, 2026 · filed Sep 30, 2026 · filing ↗
Stake reported in the company · event of Sep 18, 2026 · filed Sep 25, 2026 · filing ↗
Plus 28 more, in its EDGAR filings.
What changed this quarter
315 positions with a change (69 new, 81 added to, 111 trimmed, 54 sold); also, 28 entered through an IPO, 43 exited through an acquisition or merger, 67 entered through a spin-off. 12 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Janus Henderson Group+814%more sharesIncreased0.8% → 8.3%
- Nuvalent+4.9 ppof portfolioNew— → 5.6%
- Apogee Therapeutics+4.8 ppof portfolioNew— → 5.5%
- TopBuild+4.7 ppof portfolioNew— → 5.3%
- Brighthouse Financial−89%fewer sharesReduced3.2% → 0.4%
- Catalyst Pharmaceuticals+2.5 ppof portfolioNew— → 2.9%
- Select Medical Holdings+163%more sharesIncreased1.5% → 4.5%
- Hudbay Minerals+1.9 ppof portfolioNew— → 2.1%
- Electronic Arts−85%fewer sharesReduced1.9% → 0.3%
- Caesars Entertainment+1.6 ppof portfolioNew— → 1.9%
- Esperion Therapeutics+1.6 ppof portfolioNew— → 1.8%
- DigitalBridge Group−47%fewer sharesReduced3.2% → 2.0%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Janus Henderson GroupJHG8.3%
- Nuvalent5.6%
- Apogee Therapeutics5.5%
- TopBuildBLD5.3%
- Select Medical Holdings4.5%
- Catalyst Pharmaceuticals2.9%
- Hudbay MineralsHBM2.1%
- DigitalBridge GroupDBRG2.0%
- Chart Industries1.9%
- Caesars EntertainmentCZR1.9%
- Esperion Therapeutics1.8%
- Webster FinancialWBS1.8%
- Sila Realty Trust1.7%
- PenumbraPEN1.3%
- Global Business Travel GroupGBTG1.2%
Portfolio by sector
- ● SPAC / vehículos 37%
- ● Health Care 23%
- ● Financials 13%
- ● Industrials 12%
- ● Real Estate 3%
- ● Communication Services 3%
- ● Materials 2%
- ● Information Technology 2%
- ● Consumer Discretionary 2%
- ● Utilities 1%
- ● No sector 1%
Declared options (11)
Besides stocks, Glazer Capital declared 9 puts (they gain if the stock falls) and 2 calls (they gain if it rises) with a notional of $13.0M. The 13F reports the value of the underlying shares, not the premium paid, so these figures look large and are not added to the portfolio. Nor does it say whether the option is bought or written, or its strike or expiry: it may be a hedge.
- PUTWarner Bros. DiscoveryWBD$4.4M
- PUTPenumbraPENnew this quarter$3.5M
- PUTTopBuildBLDnew this quarter$1.8M
- PUTTransoceanRIG$1.7M
- PUTElectronic ArtsEA$756K
- PUTBrighthouse FinancialBHF$456K
- PUTLiveRamp HoldingsRAMPnew this quarter$343K
- CALLQXOQXOnew this quarter$85.0K
- PUTOrganonOGNnew this quarter$29.0K
- PUTIonQIONQnew this quarter$17.0K
- CALLCaesars EntertainmentCZRnew this quarter$3.0K
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified: we have not assigned a type because we found no document that is enough to tell. Most 13F filers are in this situation: we only review in depth those that meet the portfolio criteria.
Not counted as a concentrated manager: its portfolio is not within 5 to 100 positions; its top 10 positions are under 45%; it turns over more than 50% of the portfolio per quarter. Its portfolio is shown all the same, but it is left out of manager counts, the consensus and the ranking. How this is decided
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- BVFInvestment firm · $3.9 bn
- C WorldWide Group Holding A/SInvestment firm · $4.0 bn
- Marsico Capital ManagementInvestment firm · $3.8 bn
- PAR Capital ManagementInvestment firm · $4.0 bn
- Hamlin Capital ManagementInvestment firm · $4.0 bn
- Locust Wood Capital AdvisersInvestment firm · $4.1 bn